- Home
- HASI vs PTCT Comparison
HASI vs PTCT Comparison
Compare HASI & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HASI
- PTCT
- Stock Information
- Founded
- HASI 1981
- PTCT 1998
- Country
- HASI United States
- PTCT United States
- Employees
- HASI N/A
- PTCT N/A
- Industry
- HASI Real Estate Investment Trusts
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- HASI Real Estate
- PTCT Health Care
- Exchange
- HASI Nasdaq
- PTCT Nasdaq
- Market Cap
- HASI 3.4B
- PTCT 3.9B
- IPO Year
- HASI 2013
- PTCT 2013
- Fundamental
- Price
- HASI $27.20
- PTCT $48.55
- Analyst Decision
- HASI Strong Buy
- PTCT Buy
- Analyst Count
- HASI 9
- PTCT 14
- Target Price
- HASI $38.33
- PTCT $63.57
- AVG Volume (30 Days)
- HASI 1.8M
- PTCT 1.1M
- Earning Date
- HASI 07-31-2025
- PTCT 08-07-2025
- Dividend Yield
- HASI 6.07%
- PTCT N/A
- EPS Growth
- HASI N/A
- PTCT N/A
- EPS
- HASI 1.08
- PTCT 7.51
- Revenue
- HASI $126,702,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- HASI $189.49
- PTCT $121.37
- Revenue Next Year
- HASI $14.03
- PTCT N/A
- P/E Ratio
- HASI $25.37
- PTCT $6.46
- Revenue Growth
- HASI N/A
- PTCT 91.12
- 52 Week Low
- HASI $21.98
- PTCT $29.02
- 52 Week High
- HASI $36.56
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- HASI 54.56
- PTCT 46.94
- Support Level
- HASI $26.36
- PTCT $47.52
- Resistance Level
- HASI $27.92
- PTCT $49.73
- Average True Range (ATR)
- HASI 0.81
- PTCT 1.46
- MACD
- HASI 0.03
- PTCT -0.19
- Stochastic Oscillator
- HASI 63.64
- PTCT 36.28
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.